Cell line · CVCL_0395
LNCaP
Cancer cell line, Homo sapiens. Prostate carcinoma. 236 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. LNCaP. Cell lines, record CVCL_0395. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0395
On this page
Cell line
As Cellosaurus gives it.
- Name
- LNCaP
- Accession
- CVCL_0395
- RRID
- RRID:CVCL_0395
- Synonyms
- LNCAP, LNCap, Ln-Cap, LNCaP-RPCI, Lymph Node Carcinoma of the prostate
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- 50Y
- Category
- Cancer cell line
- Diseases
- Prostate carcinoma (NCIt C4863)
- Derived from
- Left supraclavicular lymph node (metastatic)
- Entry created
- 2012-04-04
- Entry updated
- 2026-06-25
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers236
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| In vivo validation of intramolecular bivalent glues targeting PSMA reveals potent and tissue-selective BRD4 degradation in prostate cancer. | Acta Pharm Sin B | 2026 | Its Methods give the RRID and name the line | PubMed | |
| The VCPIP1-UBE3A Deubiquitination-Ubiquitination Cascade Contributes to Castration-Resistant Prostate Cancer Progression. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Physiological elasticity and topography modulate in vitro prostate cancer cell behavior. | iScience | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Profiling crystal engineered ligands for targeting treatment resistant androgen receptors. | Front Pharmacol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Cinerascensosides A and B, Two New Cytotoxic Sulfated Saponins From the Sea Cucumber Holothuria cinerascens. | Chem Biodivers | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Senolytic Interventions Enhance the Anti-metastatic Activity of Chemotherapy in Prostate Cancer. | Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Castration-resistant prostate cancer cells are addicted to the high activity of cyclin-dependent kinase 2. | Mol Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Sarcosine-Based Pharmacokinetic Optimization and Fluorescent Dye Library Evaluation of Dual-Labeled PSMA Inhibitors for Fluorescence-Guided Surgery. | Pharmaceuticals (Basel) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| The Laron Syndrome Mouse Model Reveals a Potential Contribution of Methylglyoxal-Derived Glycative Stress to IGF-1-Driven Prostate Cancer Progression. | Biology (Basel) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A stress-adaptive lipid kinase axis defines metabolic vulnerabilities in neuroendocrine prostate cancer. | Cancer Cell | 2026 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 236
See all 236 papersRelatives30
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | EDITGENE LNCaP-CopGFP | CVCL_F6AA | Cell lines | |
| Derived from it | EDITGENE LNCaP-FLUC | CVCL_F5T1 | Cell lines | |
| Derived from it | HyCyte LNCaP KO-hFOXA1 | CVCL_E1LT | Cell lines | |
| Derived from it | HyCyte LNCaP-Luc | CVCL_E3HT | Cell lines | |
| Derived from it | LNCaP 104-S | CVCL_M126 | Cell lines | |
| Derived from it | LNCaP C-33 | CVCL_M129 | Cell lines | |
| Derived from it | LNCaP C4 | CVCL_4783 | Cell lines | |
| Derived from it | LNCaP C5 | CVCL_M132 | Cell lines | |
| Derived from it | LNCaP M | CVCL_M133 | Cell lines | |
| Derived from it | LNCaP clone FGC | CVCL_1379 | Cell lines |
1 to 10 of 30
See all 30 relativesCell banks5
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| CCTCC | GDC0283 | Cellosaurus | |
| CCTCC | GDC0284 | Cellosaurus | |
| CLS | 300265 | CLS | |
| DSMZ | ACC-256 | DSMZ | |
| EDITGENE | EDC00222 | EDITGENE |
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0395
GET https://conductscience.org/api/cell-lines/v1/CVCL_0395/papers?page=2